Articles

Plerixafor enables safe, rapid, efficient mobilization of hematopoietic stem cells in sickle cell disease patients after exchange transfusion

Biotherapy Clinical Investigation Center, Groupe Hospitalier Universitaire Ouest, Assistance Publique-Hôpitaux de Paris, INSERM CIC 1416, France;Laboratory of Human Lymphohematopoiesis, INSERM UMR 1163, Imagine Institute, Paris, France;Paris Descartes University – Sorbonne Paris Cité, Imagine Institute, France
Department of Biotherapy, Necker Children’s Hospital, Assistance Publique-Hôpitaux de Paris, France
Biotherapy Clinical Investigation Center, Groupe Hospitalier Universitaire Ouest, Assistance Publique-Hôpitaux de Paris, INSERM CIC 1416, France;Department of Biotherapy, Necker Children’s Hospital, Assistance Publique-Hôpitaux de Paris, France
Biotherapy Clinical Investigation Center, Groupe Hospitalier Universitaire Ouest, Assistance Publique-Hôpitaux de Paris, INSERM CIC 1416, France;Department of Biotherapy, Necker Children’s Hospital, Assistance Publique-Hôpitaux de Paris, France
Paris Descartes University – Sorbonne Paris Cité, Imagine Institute, France;Laboratory of Chromatin and Gene Regulation during Development, INSERM UMR1163, Imagine Institute, Paris, France;Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy
Laboratory of Human Lymphohematopoiesis, INSERM UMR 1163, Imagine Institute, Paris, France;Paris Descartes University – Sorbonne Paris Cité, Imagine Institute, France;Paris Diderot University – Sorbonne Paris Cité, France
Biotherapy Clinical Investigation Center, Groupe Hospitalier Universitaire Ouest, Assistance Publique-Hôpitaux de Paris, INSERM CIC 1416, France;Department of Biotherapy, Necker Children’s Hospital, Assistance Publique-Hôpitaux de Paris, France
Biotherapy Clinical Investigation Center, Groupe Hospitalier Universitaire Ouest, Assistance Publique-Hôpitaux de Paris, INSERM CIC 1416, France;Laboratory of Human Lymphohematopoiesis, INSERM UMR 1163, Imagine Institute, Paris, France;Paris Descartes University – Sorbonne Paris Cité, Imagine Institute, France
Biotherapy Clinical Investigation Center, Groupe Hospitalier Universitaire Ouest, Assistance Publique-Hôpitaux de Paris, INSERM CIC 1416, France;Department of Biotherapy, Necker Children’s Hospital, Assistance Publique-Hôpitaux de Paris, France
Biotherapy Clinical Investigation Center, Groupe Hospitalier Universitaire Ouest, Assistance Publique-Hôpitaux de Paris, INSERM CIC 1416, France;Department of Biotherapy, Necker Children’s Hospital, Assistance Publique-Hôpitaux de Paris, France
Biotherapy Clinical Investigation Center, Groupe Hospitalier Universitaire Ouest, Assistance Publique-Hôpitaux de Paris, INSERM CIC 1416, France;Department of Biotherapy, Necker Children’s Hospital, Assistance Publique-Hôpitaux de Paris, France
Paris Descartes University – Sorbonne Paris Cité, Imagine Institute, France;Laboratory of Chromatin and Gene Regulation during Development, INSERM UMR1163, Imagine Institute, Paris, France
Biotherapy Clinical Investigation Center, Groupe Hospitalier Universitaire Ouest, Assistance Publique-Hôpitaux de Paris, INSERM CIC 1416, France;Department of Biotherapy, Necker Children’s Hospital, Assistance Publique-Hôpitaux de Paris, France
Biotherapy Clinical Investigation Center, Groupe Hospitalier Universitaire Ouest, Assistance Publique-Hôpitaux de Paris, INSERM CIC 1416, France;Department of Biotherapy, Necker Children’s Hospital, Assistance Publique-Hôpitaux de Paris, France
Mère-Enfant Clinical Investigation Center, Groupe Hospitalier Necker Cochin, Assistance Publique-Hôpitaux de Paris, France
Intensive Care Unit, Anaesthesia and SAMU de Paris, Necker Hospital, Assistance Publique- Hôpitaux de Paris, France;Paris Descartes University – Sorbonne Paris Cité, France
Department of Biotherapy, Necker Children’s Hospital, Assistance Publique-Hôpitaux de Paris, France
Laboratory of Human Lymphohematopoiesis, INSERM UMR 1163, Imagine Institute, Paris, France;Paris Descartes University – Sorbonne Paris Cité, Imagine Institute, France;Department of Biotherapy, Necker Children’s Hospital, Assistance Publique-Hôpitaux de Paris, France
Laboratory of Chromatin and Gene Regulation during Development, INSERM UMR1163, Imagine Institute, Paris, France
Biotherapy Clinical Investigation Center, Groupe Hospitalier Universitaire Ouest, Assistance Publique-Hôpitaux de Paris, INSERM CIC 1416, France;Laboratory of Human Lymphohematopoiesis, INSERM UMR 1163, Imagine Institute, Paris, France;Paris Descartes University – Sorbonne Paris Cité, Imagine Institute, France
Biotherapy Clinical Investigation Center, Groupe Hospitalier Universitaire Ouest, Assistance Publique-Hôpitaux de Paris, INSERM CIC 1416, France;Laboratory of Human Lymphohematopoiesis, INSERM UMR 1163, Imagine Institute, Paris, France;Paris Descartes University – Sorbonne Paris Cité, Imagine Institute, France;Department of Biotherapy, Necker Children’s Hospital, Assistance Publique-Hôpitaux de Paris, France
Vol. 103 No. 5 (2018): May, 2018 https://doi.org/10.3324/haematol.2017.184788